原位黑色素瘤亚临床扩散的临床相关因素
该回顾性横断面研究纳入674例连续原位黑色素瘤(627例接受Mohs手术及MART-1免疫染色),分析亚临床扩散与临床特征的相关性。多因素分析显示,头颈部、肢端或胫前部位、既往治疗史、术前大小>1 cm及年龄≥60岁与亚临床扩散风险升高显著相关,且风险随临床危险因素数量增加而增加。
要点
- 头颈部、肢端或胫前部位的原位黑色素瘤亚临床扩散风险显著升高(OR 1.97)。
- 既往治疗史(OR 2.77)、术前大小>1 cm(OR 1.74)及年龄≥60岁(OR 1.47)亦为危险因素。
- 临床危险因素数量越多,亚临床扩散风险越高,可用于术前分诊。
核心结论
- 明确原位黑色素瘤亚临床扩散的危险因素有助于优化分诊,选择合适的手术切缘评估技术。
研究设计与样本
- 回顾性横断面研究,纳入674例连续原位黑色素瘤,其中627例接受Mohs手术及MART-1免疫染色。
主要发现
- 单因素和多因素分析均显示头颈部、肢端或胫前部位与亚临床扩散风险升高显著相关(OR 1.97,95% CI 1.41-3.40)。
- 既往治疗史者亚临床扩散风险升高(OR 2.77,95% CI 1.74-4.420)。
- 术前大小>1 cm者亚临床扩散风险升高(OR 1.74,95% CI 1.23-2.46,P = .002)。
- 年龄≥60岁者亚临床扩散风险升高(OR 1.47,95% CI 1.01-2.13,P = .042)。
- 计数预测模型显示亚临床扩散风险随临床危险因素数量增加而增加。
临床怎么用
- 对于具有头颈部、肢端或胫前部位、既往治疗史、术前大小>1 cm或年龄≥60岁等危险因素的原位黑色素瘤,应警惕亚临床扩散。
- 可根据临床危险因素数量评估亚临床扩散风险,优化手术切缘评估技术的选择。
局限性
- 单中心、回顾性研究设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Subclinical spread of in situ melanoma occurs at a wide frequency, ranging from 12% to 71%. OBJECTIVE: To identify clinical factors associated with subclinical spread of in situ melanoma. METHODS: We used a retrospective, cross-sectional study of 674 consecutive in situ melanomas to examine 627 patients treated with Mohs surgery and melanoma antigen recognized by T cells 1 immunostaining. The presence of subclinical spread was correlated with clinical characteristics. Univariate and multivariate logistic regression analyses were performed to generate odds ratios (ORs) and 95% confidence intervals (CIs). RESULTS: Both univariate and multivariate analyses demonstrated significantly increased odds for subclinical spread of in situ melanomas when they were located on the head or neck, at acral sites, or on the pretibial leg (OR 1.97, 95% CI 1.41-3.40); in persons with a history of prior treatment (OR 2.77, 95% CI 1.74-4.420); melanomas of preoperative size >1 cm (OR 1.74, 95% CI 1.23-2.46, P = .002); or in persons ≥60 years old (OR 1.47, 95% CI 1.01-2.13, P = .042). A count prediction model demonstrated that the risk for subclinical spread increased with the number of clinical risk factors. LIMITATION: We used a single-site, retrospective study design. CONCLUSION: Clarifying the risk factors for subclinical spread might help to refine triage of in situ melanomas to the appropriate surgical techniques for margin assessment prior to reconstruction.
引用
- Shin TM, Etzkorn JR, Sobanko JF, et al. Clinical factors associated with subclinical spread of in situ melanoma. J Am Acad Dermatol. 2017. PMID: 28073583. doi:10.1016/j.jaad.2016.10.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。